FORT MYERS, Fla. (AP) — FORT MYERS, Fla. (AP) — NeoGenomics Inc. (NEO) on Wednesday reported a loss of $7.5 million in its third quarter.
The Fort Myers, Florida-based company said it had a loss of 6 cents per share. Earnings, adjusted for stock option expense and amortization costs, came to 7 cents per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 6 cents per share.
The operator of cancer-focused testing laboratories posted revenue of $209.3 million in the period.
NeoGenomics expects full-year earnings in the range of 21 cents to 22 cents per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NEO at https://www.zacks.com/ap/NEO
